持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/03/21 | 8,670 | 8,800 | 8,670 | 8,740 | +40 | +0.5% | 20,900 |
| 2017/03/17 | 8,690 | 8,750 | 8,660 | 8,700 | -100 | -1.1% | 28,700 |
| 2017/03/16 | 8,800 | 8,840 | 8,760 | 8,800 | -70 | -0.8% | 23,600 |
| 2017/03/15 | 8,850 | 8,880 | 8,810 | 8,870 | ±0 | ±0% | 21,500 |
| 2017/03/14 | 8,870 | 8,900 | 8,860 | 8,870 | +50 | +0.6% | 21,800 |
| 2017/03/13 | 8,770 | 8,870 | 8,750 | 8,820 | +80 | +0.9% | 20,600 |
| 2017/03/10 | 8,690 | 8,770 | 8,640 | 8,740 | +190 | +2.2% | 29,400 |
| 2017/03/09 | 8,590 | 8,620 | 8,530 | 8,550 | -30 | -0.3% | 17,900 |
| 2017/03/08 | 8,700 | 8,700 | 8,560 | 8,580 | -30 | -0.3% | 20,600 |
| 2017/03/07 | 8,660 | 8,660 | 8,580 | 8,610 | +30 | +0.3% | 10,100 |
| 2017/03/06 | 8,660 | 8,720 | 8,580 | 8,580 | -120 | -1.4% | 22,800 |
| 2017/03/03 | 8,700 | 8,750 | 8,660 | 8,700 | ±0 | ±0% | 19,500 |
| 2017/03/02 | 8,770 | 8,770 | 8,660 | 8,700 | +60 | +0.7% | 15,100 |
| 2017/03/01 | 8,530 | 8,650 | 8,490 | 8,640 | +170 | +2% | 29,600 |
| 2017/02/28 | 8,510 | 8,570 | 8,470 | 8,470 | -20 | -0.2% | 22,400 |
| 2017/02/27 | 8,490 | 8,500 | 8,370 | 8,490 | ±0 | ±0% | 19,500 |
| 2017/02/24 | 8,500 | 8,530 | 8,420 | 8,490 | +20 | +0.2% | 23,000 |
| 2017/02/23 | 8,450 | 8,490 | 8,410 | 8,470 | +60 | +0.7% | 14,900 |
| 2017/02/22 | 8,410 | 8,430 | 8,360 | 8,410 | ±0 | ±0% | 13,700 |
| 2017/02/21 | 8,350 | 8,460 | 8,350 | 8,410 | -20 | -0.2% | 16,900 |
| 2017/02/20 | 8,300 | 8,450 | 8,290 | 8,430 | +20 | +0.2% | 17,700 |
| 2017/02/17 | 8,360 | 8,430 | 8,300 | 8,410 | ±0 | ±0% | 19,600 |
| 2017/02/16 | 8,400 | 8,460 | 8,390 | 8,410 | +30 | +0.4% | 17,700 |
| 2017/02/15 | 8,380 | 8,430 | 8,230 | 8,380 | +100 | +1.2% | 56,900 |
| 2017/02/14 | 8,350 | 8,370 | 8,280 | 8,280 | -50 | -0.6% | 35,000 |
| 2017/02/13 | 8,380 | 8,400 | 8,270 | 8,330 | +30 | +0.4% | 50,200 |
| 2017/02/10 | 8,250 | 8,370 | 8,250 | 8,300 | +150 | +1.8% | 41,100 |
| 2017/02/09 | 8,190 | 8,200 | 8,130 | 8,150 | ±0 | ±0% | 23,500 |
| 2017/02/08 | 8,180 | 8,180 | 8,090 | 8,150 | -60 | -0.7% | 21,700 |
| 2017/02/07 | 8,160 | 8,260 | 8,150 | 8,210 | -10 | -0.1% | 31,100 |
| 2017/02/06 | 8,210 | 8,240 | 8,140 | 8,220 | -10 | -0.1% | 28,600 |
| 2017/02/03 | 8,020 | 8,260 | 8,020 | 8,230 | +210 | +2.6% | 41,500 |
| 2017/02/02 | 8,140 | 8,210 | 8,000 | 8,020 | -120 | -1.5% | 36,200 |
| 2017/02/01 | 8,020 | 8,140 | 7,980 | 8,140 | +50 | +0.6% | 36,200 |
| 2017/01/31 | 8,050 | 8,150 | 8,020 | 8,090 | +40 | +0.5% | 27,800 |
| 2017/01/30 | 7,990 | 8,200 | 7,960 | 8,050 | ±0 | ±0% | 29,700 |
| 2017/01/27 | 8,190 | 8,190 | 8,010 | 8,050 | -60 | -0.7% | 24,100 |
| 2017/01/26 | 8,100 | 8,160 | 8,070 | 8,110 | +100 | +1.2% | 23,600 |
| 2017/01/25 | 8,010 | 8,040 | 7,920 | 8,010 | +50 | +0.6% | 20,100 |
| 2017/01/24 | 7,950 | 8,060 | 7,930 | 7,960 | -70 | -0.9% | 13,500 |
| 2017/01/23 | 8,050 | 8,080 | 7,910 | 8,030 | -130 | -1.6% | 25,000 |
| 2017/01/20 | 8,130 | 8,220 | 8,120 | 8,160 | -20 | -0.2% | 24,400 |
| 2017/01/19 | 8,150 | 8,210 | 8,090 | 8,180 | +70 | +0.9% | 22,500 |
| 2017/01/18 | 8,260 | 8,260 | 8,080 | 8,110 | -100 | -1.2% | 17,300 |
| 2017/01/17 | 8,370 | 8,370 | 8,200 | 8,210 | -80 | -1% | 21,900 |
| 2017/01/16 | 8,230 | 8,320 | 8,190 | 8,290 | -20 | -0.2% | 20,400 |
| 2017/01/13 | 8,200 | 8,310 | 8,160 | 8,310 | +30 | +0.4% | 55,000 |
| 2017/01/12 | 8,460 | 8,460 | 8,240 | 8,280 | -250 | -2.9% | 40,200 |
| 2017/01/11 | 8,410 | 8,550 | 8,340 | 8,530 | +110 | +1.3% | 45,500 |
| 2017/01/10 | 8,450 | 8,520 | 8,370 | 8,420 | -30 | -0.4% | 37,500 |
2001～
2050
件表示中 / 3709件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 299,600円 | +5.1% | -7.0% | 2.67% | 19.67倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 東和薬品 | 306,000円 | +7.9% | -3.3% | 2.61% | 8.51倍 | 0.88倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 216,900円 | +3.1% | -6.5% | 2.21% | 10.06倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,400円 | -2.4% | -52.3% | 3.82% | 17.88倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 92,100円 | +20.3% | - | 0.00% | 163.29倍 | 1.21倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
